Literature DB >> 29243842

Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA.

Helia Namazi1,2, Elham Mohit1,3, Iman Namazi4, Sarah Rajabi5, Azam Samadian5, Ensiyeh Hajizadeh-Saffar5, Nasser Aghdami5, Hossein Baharvand5,6.   

Abstract

Exosomes are required for the regenerative effects of human cardiosphere-derived cells (CDCs). Studies show that they mimic the cardioprotective benefits of CDCs in rodents and porcine myocardial infarction (MI) models. Hypoxic preconditioning of stem cells increases the cardioprotective effects of exosomes in MI models by enhancing angiogenesis. Several exosomal microRNAs (miRNAs) up-regulate in response to hypoxia and play a role in cardioprotective and pro-angiogenic effects. In this study, we have demonstrated that human CDCs secreted exosomes under hypoxic conditions (1% O2 for 2 days) enhanced tube formation by human umbilical vein endothelial cells (HUVECs) at a concentration of 25 µg/mL. Pro-angiogenic exosomal miRNAs including miR-126, miR-130a, and miR-210 showed a substantial increase (>2-, >2-, and >4-fold, respectively) in the hypoxic exosomes compared to normoxic CDC-derived exosomes. Our study suggested a significant benefit of hypoxic CDC exosomes for the treatment of cardiac diseases by induction of angiogenesis via enrichment of pro-angiogenic exosomal miRNAs.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  angiogenesis; cardiosphere-derived cells; exosomes; microRNA

Mesh:

Substances:

Year:  2018        PMID: 29243842     DOI: 10.1002/jcb.26621

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  36 in total

Review 1.  microRNAs and cardiac stem cells in heart development and disease.

Authors:  Bo Li; Xianmei Meng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2018-05-28       Impact factor: 7.851

Review 2.  Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.

Authors:  Susmita Sil; Raghubendra Singh Dagur; Ke Liao; Eric S Peeples; Guoku Hu; Palsamy Periyasamy; Shilpa Buch
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

Review 3.  Stem Cell-derived Exosomal MicroRNA as Therapy for Vascular Age-related Diseases.

Authors:  Hang Ren; Ziyuan Guo; Yang Liu; Chunli Song
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

Review 4.  Cardiovascular Exosomes and MicroRNAs in Cardiovascular Physiology and Pathophysiology.

Authors:  Robert J Henning
Journal:  J Cardiovasc Transl Res       Date:  2020-06-25       Impact factor: 4.132

5.  The Effect of Growth Stage and Isolation Method on Properties of ClearColi™ Outer Membrane Vesicles (OMVs).

Authors:  Elham Sharif; Zohre Eftekhari; Elham Mohit
Journal:  Curr Microbiol       Date:  2021-03-09       Impact factor: 2.188

Review 6.  Cellular signaling cross-talk between different cardiac cell populations: an insight into the role of exosomes in the heart diseases and therapy.

Authors:  Binh Yen Nguyen; Tayyiba Azam; Xin Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-29       Impact factor: 4.733

Review 7.  Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations.

Authors:  Majid Babaei; Jafar Rezaie
Journal:  J Transl Med       Date:  2021-05-08       Impact factor: 5.531

8.  Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment.

Authors:  Stephanie M Kronstadt; Alex E Pottash; Daniel Levy; Sheng Wang; Wei Chao; Steven M Jay
Journal:  Adv Ther (Weinh)       Date:  2021-04-29

Review 9.  Biomimetic and immunomodulatory therapeutics as an alternative to natural exosomes for vascular and cardiac applications.

Authors:  Ramiro A Villarreal-Leal; John P Cooke; Bruna Corradetti
Journal:  Nanomedicine       Date:  2021-03-24       Impact factor: 6.096

10.  miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia.

Authors:  Marie Besnier; Stefano Gasparino; Rosa Vono; Elena Sangalli; Amanda Facoetti; Valentina Bollati; Laura Cantone; Germana Zaccagnini; Biagina Maimone; Paola Fuschi; Daniel Da Silva; Michele Schiavulli; Sezin Aday; Massimo Caputo; Paolo Madeddu; Costanza Emanueli; Fabio Martelli; Gaia Spinetti
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.